foxo4-dri peptide senolytic animal model 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI induces keloid senescent fibroblast
FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics The Journal of Prevention of Alzheimer's Disease Springer Nature Link Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



